BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Expression data from J147-treated HT22 cells compared to untreated HT22 cells › mRNA and microRNA profile in colon cancer [mRNA data]

Dataset: mRNA and microRNA profile in colon cancer [mRNA data]

Compariosn of mRNA and miRNA profile in colon cancer mRNA was extracted from colon tissues for microarray analysis

Registered by ArrayExpress Uploader
View Dataset

Compariosn of mRNA and miRNA profile in colon cancer mRNA was extracted from colon tissues for microarray analysis

Species:
human

Samples:
65

Source:
E-GEOD-29621

Updated:
Dec.12, 2014

Registered:
Jul.11, 2014


Factors: (via ArrayExpress)
Sample ADJUVANT CHEMO CORRESPONDING TO GSE17536 T STAGE HISTOLOGIC GRADE SEX OVERALL SURVIVAL OS AJCC STAGING DISEASE-FREE SURVIVAL TIME DFS OS EVENT M STAGE 0 N STAGE DFS EVENT
GSM734175 Y GSM437176 3 MOD DIFF male 11.76 Stage 3 8.21 dead no; 1: metastasis): 0 2 recurrence
GSM734174 Y GSM437210 3 MOD DIFF female 54.54 Stage 3 26.92 alive no; 1: metastasis): 0 1 no recurrence
GSM734173 Y GSM437237 3 MOD DIFF male 15.28 Stage 4 NA dead no; 1: metastasis): 1 0 NA
GSM734172 Y GSM437158 3 MOD DIFF female 49.87 Stage 2 36.75 alive no; 1: metastasis): 0 0 no recurrence
GSM73417 Y GSM437129 4 MOD DIFF male 102.44 Stage 2 64.86 alive no; 1: metastasis): 0 0 no recurrence
GSM734170 N GSM437148 3 MOD DIFF female 52.14 Stage 2 52.14 alive no; 1: metastasis): 0 0 no recurrence
GSM734169 N GSM437208 3 MOD DIFF female 58.45 Stage 3 58.45 alive no; 1: metastasis): 0 1 no recurrence
GSM734168 Y GSM437185 3 WELL DIFF female 99.51 Stage 3 99.51 alive no; 1: metastasis): 0 1 no recurrence
GSM734167 N GSM437114 2 MOD DIFF male 3.64 Stage 1 3.64 alive no; 1: metastasis): 0 0 no recurrence
GSM734166 Y GSM437097 2 MOD DIFF male 59.53 Stage 1 59.53 alive no; 1: metastasis): 0 0 no recurrence
GSM734165 N GSM437101 2 MOD DIFF male 65.88 Stage 1 65.88 dead no; 1: metastasis): 0 0 no recurrence
GSM734164 N GSM437115 2 WELL DIFF male 36.59 Stage 1 23.96 alive no; 1: metastasis): 0 0 no recurrence
GSM734163 N GSM437109 2 MOD DIFF female 55.13 Stage 1 55.13 alive no; 1: metastasis): 0 0 no recurrence
GSM734162 N GSM437106 2 MOD DIFF female 67.82 Stage 1 67.82 alive no; 1: metastasis): 0 0 no recurrence
GSM73416 N GSM437107 2 WELL DIFF male 52.24 Stage 1 52.24 alive no; 1: metastasis): 0 0 no recurrence
GSM734160 N GSM437173 3 MOD DIFF female 27.15 Stage 2 27.15 dead no; 1: metastasis): 0 0 no recurrence
GSM734159 N GSM437170 3 MOD DIFF male 15.05 Stage 2 15.05 alive no; 1: metastasis): 0 0 no recurrence
GSM734158 Y GSM437169 3 MOD DIFF female 83.99 Stage 2 22.38 alive no; 1: metastasis): 0 0 recurrence
GSM734157 N GSM437162 3 MOD DIFF male 26.66 Stage 2 26.66 alive no; 1: metastasis): 0 0 no recurrence
GSM734156 N GSM437161 3 MOD DIFF male 35.9 Stage 2 35.9 alive no; 1: metastasis): 0 0 no recurrence
GSM734155 N GSM437160 3 MOD DIFF male 44.97 Stage 2 44.97 alive no; 1: metastasis): 0 0 no recurrence
GSM734154 N GSM437159 3 MOD DIFF male 25.24 Stage 2 25.24 alive no; 1: metastasis): 0 0 no recurrence
GSM734153 Y GSM437121 4 MOD DIFF female 120.62 Stage 2 27.64 alive no; 1: metastasis): 0 0 recurrence
GSM734152 Y GSM437155 3 MOD DIFF female 37.67 Stage 2 17.95 alive no; 1: metastasis): 0 0 no recurrence
GSM73415 Y GSM437152 3 MOD DIFF female 58.45 Stage 2 46.71 alive no; 1: metastasis): 0 0 no recurrence
GSM734150 N GSM437150 3 WELL DIFF male 59.96 Stage 2 59.96 alive no; 1: metastasis): 0 0 no recurrence
GSM734149 N GSM437147 3 POORLY DIFF female 34.09 Stage 2 24.19 alive no; 1: metastasis): 0 0 no recurrence
GSM734148 N NA 4 POORLY DIFF female 61.57 Stage 2 61.57 alive no; 1: metastasis): X X no recurrence
GSM734147 Y GSM437146 3 MOD DIFF male 63.25 Stage 2 63.25 alive no; 1: metastasis): 0 0 no recurrence
GSM734146 N GSM437144 3 MOD DIFF male 37.31 Stage 2 37.31 dead no; 1: metastasis): 0 0 no recurrence
GSM734145 N GSM437118 3 POORLY DIFF female 55.33 Stage 2 55.33 alive no; 1: metastasis): 0 0 no recurrence
GSM734144 Y GSM437128 3 MOD DIFF male 88.99 Stage 2 88.99 alive no; 1: metastasis): 0 0 no recurrence
GSM734143 N GSM437126 3 MOD DIFF female 52.5 Stage 2 52.5 dead no; 1: metastasis): 0 0 no recurrence
GSM734142 Y GSM437269 3 MOD DIFF male 22.35 Stage 4 NA alive no; 1: metastasis): 1 0 NA
GSM73414 N GSM437264 4 MOD DIFF female 9.96 Stage 4 9.96 dead no; 1: metastasis): 1 0 no recurrence
GSM734140 Y GSM437263 3 MOD DIFF male 14.56 Stage 4 NA dead no; 1: metastasis): 1 1 NA
GSM734139 N GSM437262 3 MOD DIFF male 15.25 Stage 4 NA dead no; 1: metastasis): 1 1 NA
GSM734138 Y GSM437255 3 MOD DIFF female 60.75 Stage 4 55.19 alive no; 1: metastasis): 1 1 no recurrence
GSM734137 Y GSM437259 3 MOD DIFF male 31.85 Stage 4 NA alive no; 1: metastasis): 1 1 NA
GSM734136 Y GSM437253 3 POORLY DIFF male 1.44 Stage 4 NA dead no; 1: metastasis): 1 1 NA
GSM734135 Y GSM437252 3 MOD DIFF female 34.02 Stage 4 NA dead no; 1: metastasis): 1 2 NA
GSM734134 Y GSM437231 3 MOD DIFF male 18.54 Stage 4 NA dead no; 1: metastasis): 1 1 NA
GSM734133 Y GSM437240 3 MOD DIFF male 28.89 Stage 4 NA dead no; 1: metastasis): 1 2 NA
GSM734132 Y GSM437238 3 MOD DIFF male 95.07 Stage 4 82.61 alive no; 1: metastasis): 1 1 no recurrence
GSM73413 Y GSM437236 3 MOD DIFF male 5.72 Stage 4 NA dead no; 1: metastasis): 1 1 NA
GSM734130 N GSM437239 3 MOD DIFF male 4.96 Stage 4 NA dead no; 1: metastasis): 1 1 NA
GSM734129 Y GSM437211 3 POORLY DIFF female 19.03 Stage 3 8.58 dead no; 1: metastasis): 0 1 recurrence
GSM734128 N NA 3 MOD DIFF male 85.93 Stage 3 79.46 dead no; 1: metastasis): 0 1 recurrence
GSM734127 Y GSM437195 3 MOD DIFF male 59.07 Stage 3 59.07 dead no; 1: metastasis): 0 2 no recurrence
GSM734126 Y GSM437191 3 MOD DIFF female 85.61 Stage 3 85.61 alive no; 1: metastasis): 0 1 no recurrence
GSM734125 Y GSM437186 2 MOD DIFF male 20.44 Stage 3 20.44 dead no; 1: metastasis): 0 2 no recurrence
GSM734124 N GSM437184 3 POORLY DIFF male 6.11 Stage 3 5.35 dead no; 1: metastasis): 0 1 recurrence
GSM734123 Y GSM437196 3 POORLY DIFF male 47.8 Stage 3 47.8 dead no; 1: metastasis): 0 1 no recurrence
GSM734122 Y GSM437175 3 MOD DIFF male 105.17 Stage 3 105.17 alive no; 1: metastasis): 0 1 no recurrence
GSM73412 Y GSM437192 3 MOD DIFF male 78.87 Stage 3 64.33 alive no; 1: metastasis): 0 1 no recurrence
GSM734120 Y GSM437151 3 MOD DIFF male 47.86 Stage 2 47.86 alive no; 1: metastasis): 0 0 no recurrence
GSM734119 N GSM437246 3 MOD DIFF female 5.12 Stage 4 NA dead no; 1: metastasis): 1 2 NA
GSM734118 Y GSM437265 3 MOD DIFF male 8.94 Stage 4 8.94 dead no; 1: metastasis): 1 1 no recurrence
GSM734117 Y GSM437261 4 MOD DIFF male 42.27 Stage 4 13.08 alive no; 1: metastasis): 1 0 recurrence
GSM734116 Y GSM437205 3 MOD DIFF female 38.72 Stage 3 38.72 dead no; 1: metastasis): 0 1 no recurrence
GSM734115 Y GSM437266 3 POORLY DIFF female 32.67 Stage 4 17.32 alive no; 1: metastasis): 1 2 recurrence
GSM734114 Y GSM437209 3 POORLY DIFF male 59.34 Stage 3 59.34 alive no; 1: metastasis): 0 1 no recurrence
GSM734113 Y GSM437199 3 MOD DIFF male 74.07 Stage 3 24.85 alive no; 1: metastasis): 0 1 recurrence
GSM734112 N GSM437206 3 MOD DIFF female 54.9 Stage 3 54.9 dead no; 1: metastasis): 0 1 no recurrence
GSM734 Y GSM437213 3 POORLY DIFF male 52.86 Stage 3 52.86 alive no; 1: metastasis): 0 1 no recurrence

Tags

  • cancer
  • colon
  • colon cancer

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2026 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use